a public good project by the
Synthesis
Company
of California

© 2026

Xiaoxing Liu | doi.page

0 works0 citations0 h-index

Xiaoxing Liu

Xuzhou Medical College(CN)Beijing Technology and Business University(CN)Wenzhou Medical University(CN)Xuzhou No.1 People's Hospital(CN)Dongyang People's Hospital(CN)Southeast University(CN)

Publications by Year

Research Areas

Retinal Development and Disorders, Neurotransmitter Receptor Influence on Behavior, MicroRNA in disease regulation, Advanced Glycation End Products research, Circular RNAs in diseases

Most-Cited Works

→ The microbiota-gut-brain axis in sleep disorders(2022)247 cited
→ An Entropy-based gene selection method for cancer classification using microarray data(2005)183 cited
→ PRPF4 mutations cause autosomal dominant retinitis pigmentosa(2014)125 cited
→ Inhibiting the CD8+ T cell infiltration in the tumor microenvironment after radiotherapy is an important mechanism of radioresistance(2018)85 cited
→ Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT/ERK signaling(2021)40 cited
→ Novel and Recurrent MYO7A Mutations in Usher Syndrome Type 1 and Type 2(2014)36 cited

→ Targeted Next-Generation Sequencing Reveals Novel USH2A Mutations Associated with Diverse Disease Phenotypes: Implications for Clinical and Molecular Diagnosis(2014)

33 cited

→ Targeted Next-generation Sequencing Reveals Novel EYS Mutations in Chinese Families with Autosomal Recessive Retinitis Pigmentosa(2015)32 cited

→ Non-coding RNAs expression in SARS-CoV-2 infection: Pathogenesis, clinical significance and therapeutic targets(2023)27 cited

→ Tenuifoliside A promotes neurite outgrowth in PC12 cells via the PI3K/AKT and MEK/ERK/CREB signaling pathways(2015)25 cited